Mind Medicine Inc (MNMD) is expecting 169.13% growth in the next quarter: What can investors do to maximize their returns?

Mind Medicine Inc (NASDAQ: MNMD) on Tuesday, soared 3.47% from the previous trading day, before settling in for the closing price of $9.52. Within the past 52 weeks, MNMD’s price has moved between $2.41 and $11.10.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The company achieved an average annual earnings per share of 36.53%. With a float of $26.94 million, this company’s outstanding shares have now reached $41.10 million.

Considering the fact that the conglomerate employs 57 people, you should pay attention to its efficiency factor.

Mind Medicine Inc (MNMD) Insider Activity

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mind Medicine Inc is 4.36%, while institutional ownership is 61.38%. The most recent insider transaction that took place on Mar 25 ’24, was worth 156,930. In this transaction Chief Executive Officer of this company sold 16,519 shares at a rate of $9.50, taking the stock ownership to the 580,202 shares. Before that another transaction happened on Mar 25 ’24, when Company’s Chief Medical Officer sold 6,578 for $9.50, making the entire transaction worth $62,491. This insider now owns 358,452 shares in total.

Mind Medicine Inc (MNMD) Earnings and Forecasts

As on 12/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.59 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.46) by -$0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 36.53% per share during the next fiscal year.

Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators

Mind Medicine Inc (MNMD) is currently performing well based on its current performance indicators. A quick ratio of 3.22 was reported for the most recent quarter.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.45, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.47 in one year’s time.

Technical Analysis of Mind Medicine Inc (MNMD)

Compared to the last year’s volume of 1.95 million, its volume of 1.84 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 34.27%. Additionally, its Average True Range was 0.93.

During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 85.62%, which indicates a significant increase from 66.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.29% in the past 14 days, which was lower than the 104.26% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.33, while its 200-day Moving Average is $4.27. Nevertheless, the first resistance level for the watch stands at $10.16 in the near term. At $10.47, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.07. If the price goes on to break the first support level at $9.26, it is likely to go to the next support level at $8.66. Should the price break the second support level, the third support level stands at $8.35.

Mind Medicine Inc (NASDAQ: MNMD) Key Stats

Market capitalization of the company is 277.38 million based on 70,268K outstanding shares. Right now, sales total 0 K and income totals -95,730 K. The company made 0 K in profit during its latest quarter, and -23,860 K in sales during its previous quarter.